Other languages ALK-Abelló A/S

Equities

ALK B

DK0061802139

Market Closed - Nasdaq Copenhagen Other stock markets 10:59:37 2024-05-17 am EDT			5-day change	1st Jan Change
152 ^DKK	-2.50%		-0.85%	+50.20%

May. 03	Transcript : ALK-Abelló A/S, Q1 2024 Earnings Call, May 03, 2024
May. 02	ALK-Abelló A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aggiornamento sui forti movimenti della giornata: Banks, Genmab, Daimler Truck ... risultati riassunti qui!	May. 03
Actualización de las fuertes variaciones del día: Bancos, Genmab, Daimler Truck ... ¡resultados resumidos aquí!	May. 03
Les actions en mouvement : Les banques, JCDecaux, Bonduelle ... les publications de résultats résumées ici !	May. 03
ALK-Abelló A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02
ALK-Abelló A/S Updates Revenue Guidance for the Year 2024	May. 02
ALK-Abelló A/S Provides Earnings Guidance for the Year 2024	May. 02
ALK-Abelló A/S: nessuna allergia in vista	Mar. 22
EN DIRECTO DESDE LOS MERCADOS: Inditex, Aena, Acciona Energía, Iberdrola, Rovi, Adidas, Tod's, Volkswagen, CME Group...	Mar. 13
ALK-Abelló A/S: Sin alergia en el horizonte	Mar. 12
Neuzugänge im EU-Portfolio von MarketScreener	Mar. 05
Nuovo acquisto nel portafoglio Europa	Mar. 05
Nieuwe aankopen voor de Europese portefeuille	Mar. 05
Nieuwe aankopen voor de Europese portefeuille	Mar. 05
Nuevas compras en la cartera Inversor Europa	Mar. 04
Nouveaux achats dans le portefeuille Investisseur Europe PEA	Mar. 04
ALK-Abelló A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08
Alk-Abelló A/S Provides Revenue Guidance for the Year of 2024	Feb. 08
ALK-Abelló’s Carbon Reduction Targets Gets Validation from Science-Based Targets Initiative	Feb. 05
Alk's European Registration Application for House Dust Mite Slit-Tablet in Young Children Accepts for Review	Jan. 25
ALK-Abelló’s Peanut Allergy Treatment Shows Safety, Tolerability in First Part of Early-stage Trial	Jan. 18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ALK-Abelló A/S : No allergy on the horizon

March 12, 2024 at 10:20 am EDT